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CASE REPORTS
Superior vena cava (SVC) syndrome is caused by
primary bronchial carcinomas or malignant tumors
in the upper mediastinum in more than 90% of
cases. The other 5% to 10% of cases have a benign
cause, such as aneurysms of the aortic arch, con-
strictive pericarditis, mediastinal fibrosis, sarcoido-
sis, or retrosternal goiter. With the increasing use of
central venous catheters, upper extremity central
venous obstruction is occurring more frequently.1
Acute obstruction of the SVC is considered an
emergency, with a potential fatal outcome as a result
of cerebral edema with cerebellar herniation. The
slow development of SVC obstruction may be well
tolerated because collateral vessels establish with
time. At present, SVC obstruction as a result of
malignant disease is preferably treated with
endovascular stenting.2,3 However, in benign dis-
eases, surgical reconstruction can be achieved with
bypass grafting or the replacement of the obstruct-
ed SVC. Various grafts, such as ring-supported
polytetrafluorethylene (PTFE) or Dacron grafts,
have been used, but most surgeons prefer autoge-
nous grafts, such as spiral vein grafts.
We report the case of a young patient with
chronic symptomatic SVC syndrome after repeated
placement of central venous catheters for hemodial-
ysis. The patient was treated successfully with a peri-
cardial tube bypass graft. We reviewed the related
literature. In this article, we discuss the advantages
of this technique.
CASE REPORT
A 16-year-old boy had a history of facial flushing and
profuse headaches when lying face up or bending forward.
The patient also reported puffiness around his eyes and
occasional moderate swelling of the neck. No swelling in
the arms occurred. Multiple dilated veins on the anterior
chest wall and the lateral abdominal wall were present.
The patient’s medical history was significant for chron-
ic renal failure caused by focal glomerulosclerosis, which
resulted in bilateral nephrectomies. When the patient was
12 years old, a successful living related kidney transplanta-
tion was performed. Before transplantation, the patient had
multiple central venous catheters placed for hemodialysis.
A venogram revealed occlusion of the SVC at the junction
of the SVC with the azygos vein (Fig 1). The contrast
material was drained preferentially via the markedly
enlarged azygos vein distally and via intercostal veins and
abdominal collateral vessels into the inferior vena cava. 
The patient was significantly symptomatic from the
SVC obstruction and suffered from a benign disease, so
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surgery was recommended. The surgical approach was
through a median sternotomy. The SVC was found to be
thrombosed at its origin with the right atrium. The conflu-
ence of the azygos veins and right and left brachiocephalic
veins was clamped. Venous pressure as measured from the
left brachiocephalic vein was 21 mm Hg. For this reason,
no decompressive venovenous shunt was used. The peri-
cardium was mobilized between the left and right pleura,
and a rectangular piece of pericardium was harvested; we
were careful not to injure the phrenic nerves. The length
was determined by measuring the distance between the
confluence and the left atrium, and the width was estimat-
ed by comparing the diameter of the brachiocephalic veins
with a chest tube. A pericardial tube graft was created by
wrapping the pericardium around a 28F chest tube. The
visceral surface was oriented to the inner side. A 9-mm
graft was created and subsequently was sewn end-to-side to
the inferior aspect of the confluence of the brachiocephalic
veins. The proximal end of the conduit was anastomosed to
the superior aspect of the right atrial appendage (Figs 2 and
3). After restoration of flow through the conduit, the cen-
tral venous pressure in the left brachiocephalic vein
dropped to 7 mm Hg. The central venous pressure in the
conduit measured 5 to 7 mm Hg. Before the end of the
operation, adequate flow through the conduit was noted
by means of transesophageal echocardiography. Laminar
flow could be seen into the right atrium without evidence
of turbulence. 
The postoperative course was uneventful, and the
patient was discharged on the 4th day after surgery.
Collateral veins of the abdomen and the upper chest disap-
peared promptly. The patient was maintained with intra-
venous heparin in the hospital and converted to warfarin
for 6 months to keep the international normalized ratio
between 2 and 3. At follow-up 13 months after surgery, the
patient had no complaints and a magnetic resonance
angiogram revealed a patent pericardial conduit (Fig 4).
DISCUSSION
Obstruction of the SVC as a complication of pri-
mary intrathoracic malignant disease occurs in 3% to
8% of patients in these cases. The obstructions in 90%
of the cases are caused by primary bronchial carcino-
mas, mediastinal lymphomas, or other neoplasms from
the upper mediastinum, such as malignant thymomas,
Fig. 1. Bilateral upper extremity venogram. SVC is
occluded below the origin of azygos vein (arrow).
Fig. 2. Intraoperative aspect after bypass grafting of SVC
with pericardial tube graft from the confluence of right
and left brachiocephalic veins and right atrial appendage.
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goiters, or teratomas.4 About 10% of patients with
SVC syndrome have a benign cause, the most com-
mon being venous wall fibrosis with secondary throm-
bosis from long-term indwelling catheters.1,5
In the face of chronic obstruction of the SVC,
collateral routes develop to establish venous return to
the heart. The first pathway involves the azygos and
hemiazygos veins and can be established only if
obstruction occurs below the entrance of the azygos
vein into the SVC. Lumbar veins subsequently drain
into the inferior vena cava. This pathway was mainly
established in our patient. The second pathway
involves the internal mammary venous system, with
its tributaries and communication with the inferior
epigastric vein. The third and fourth collateral routes
include the thoracoepigastric vein, with its connec-
tion to the saphenous vein, and the vertebral veins.6
Benign SVC obstruction only occasionally neces-
sitates intervention because of this effective collater-
alization and because the syndrome is not progres-
sive.7,8 However, Doty et al9 reported on experiences
with 9 patients with benign SVC syndrome in whom
no improvement was observed: all required surgery.
Before surgery, our patient had not had any improve-
ment of his symptoms over time. This may be relat-
ed to increased resistance along the collateral path-
ways with secondary occlusion of established collat-
eral vessels.
Clinical symptoms can be related to the follow-
ing dramatic pathophysiologic changes that result
from SVC obstruction: venous hypertension of the
upper body, delayed circulation time, and develop-
ment of collateral venous pathways. The severity of
the changes depends on the degree of SVC narrow-
ing and the period in which they occur. The leading
symptom of SVC syndrome is venous congestion of
the upper half of the body. This may be accompa-
nied by cough, headache, nausea, dyspnea, tongue
swelling, facial swelling, and nasal stuffiness. Stridor,
hoarseness, and respiratory distress are typically
related to local tumor invasion but can also be
caused by laryngeal and airway edema. Edema and
swelling may extend and cause upper-extremity
swelling and increased collar size. The full picture
has been described as “upper-body plethora.” If the
venous pressure exceeds 50 mm Hg, cerebral edema
occurs, which results in gradual mental changes, stu-
por, or even coma.10 Death may be caused by cere-
bellar herniation. Clinical signs and symptoms may
be aggravated by bending forward or lying flat, as
with our patient.
Computed tomograpic scanning is the procedure
of choice in the diagnosis of SVC syndrome because
it can easily delineate the degree and site of com-
pression and the presence of any mediastinal or
Fig. 3. Diagram of the completed repair.
Fig. 4. T1-weighted magnetic resonance angiography.
Transverse cut of heart and great vessels. Pericardial tube
is patent (arrow).
intrathoracic mass. Magnetic resonance angiography
with gadolinium may soon replace computed
tomography as the best diagnostic test. Currently,
bilateral upper-limb contrast venography is the best
preoperative procedure with which to determine the
level and degree of SVC obstruction.11 Venography
is also important for planning purposes for the oper-
ative procedure. Patency of the internal jugular veins
may be assessed noninvasively with duplex ultra-
sound scanning.
Radiotherapy, chemotherapy, and endovascular
balloon angioplasty and stenting are the preferred
treatment options in cases of malignant SVC obstruc-
tion,2,3 although surgical reconstruction has been
reported with good results even in patients with unre-
sectable disease.12 The stenting of benign disease is
not recommended because of the longer life
expectancy, the lack of long-term follow-up, and the
possibility of stent fracture, migration, or thrombosis. 
Surgery is effective for benign SVC syndrome.9
PTFE has been reported to be a useful prosthetic
device with good short-term patency rates.
However, intimal irregularity and stenosis may
occur,13 and the inner surface consists of a collagen
matrix rather than an endothelium lining, which
makes it subject to thrombosis. Experimental and
clinical studies with vena cava replacement or bypass
graft showed that autogenous vein grafts of nearly
the same size as the original vena cava have a higher
patency rate. The femoral, subclavian, and jugular
veins have been used but with the disadvantage of
impaired venous return at the area of harvesting. 
A composite spiral vein graft constructed from
the saphenous vein to create a large venous conduit
has been the preferred graft.9,14,15 With this tech-
nique, the vein is split longitudinally and wrapped
around a stent in a spiral fashion. The edges are
sutured together to create a large conduit. One study
showed that after a mean follow-up of 7.2 years, 78%
of the grafts remained patent.9 Recurrence or pro-
gression of disease in the case of fibrosing medias-
tinitis can be prevented successfully by externally sup-
porting the vein with a PTFE graft.16 There are dis-
advantages to this technique. A long suture line may
make the graft more thrombogenic. A long segment
of saphenous vein is required to make the spiral graft,
which takes considerable time to construct.
Another autologous technique consists of pericar-
dial tube graft replacement. Pericardium has been
used extensively for various procedures in congenital
heart disease without any increase in thrombogenici-
ty. In addition, it has been used successfully for recon-
struction or bypass grafting of the SVC in cases of
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malignant obstruction.17,18 However, for SVC bypass
graft in patients with benign disease, this method has
only rarely been reported. An extensive Medline
search revealed only 1 case since 1966 in which a peri-
cardial tube graft was used for SVC syndrome as a
result of a benign disease. Larsson and Lepore19 per-
formed a series of reconstructions of large mediastinal
veins in patients with SVC syndrome. One patient
with idiopathic mediastinal fibrosis was treated with a
pericardial tube graft with a good outcome after 69
months of follow-up. The advantages of a pericardial
tube graft are its availability, the lack of a donor site
incision for saphenous vein, and a reduced recon-
struction time. In addition, autologous pericardial
grafts used for surgery in pediatric cardiac anomalies
have been shown to actually grow and enlarge with
the growth and development of the child.20 Our case
shows that the pericardial tube graft can be used as an
easily available and effective autogenous graft for SVC
reconstruction. Although cardiac herniation is a
potential complication after pericardial resection, this
complication usually occurs only if concomitant lung
resection or pneumonectomy is performed. No artifi-
cial material was used to close the pericardial defect in
our patient. We thought that postoperative anticoag-
ulation therapy with warfarin for 6 months was rea-
sonable to guarantee complete endotheliziation.
Because the patient was young and active, warfarin
was stopped after 6 months; the benefit was not justi-
fied when compared with the potential complications.
During the operation, the confluence of the right
and left brachiocephalic veins and the azygos vein
had to be clamped. The pressure obtained from the
left brachiocephalic vein was 21 mm Hg. For this rea-
son, and because no obvious changes were noted by
the anesthetist, no shunt was used. In the presence of
a significant increase over more than 30 mm Hg, a
venovenous shunt from the brachiocephalic or jugu-
lar vein to the right atrium may have been necessary.
We conclude that the pericardial tube graft is an
excellent material for bypass graft of the obstructed
SVC in patients with benign disease. To our knowl-
edge, this is the second case of pericardial tube graft
replacement of the obstructed SVC for benign dis-
ease. This technique is feasible and easy to perform,
and it has the potential for high patency rates for
long-term outcome.
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